{
    "code": "06024721",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024721",
    "time": "2020-02-25 20:44:53",
    "許可證字號": "衛署醫器輸字第024721號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4286",
    "有效日期": "112\/02\/22",
    "發證日期": "102\/02\/22",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00602472102",
    "中文品名": "羅氏BRAF V600基因突變核酸檢驗試劑",
    "英文品名": "Cobas 4800 BRAF V600 Mutation Test",
    "效能": "本產品的主要效能是偵測從福馬林固定石蠟包埋的人類黑色素瘤(melanoma)組織中萃取之DNA內BRAF V600的突變。對人類黑色素瘤而言，本試劑的使用目的是用來幫助篩選腫瘤帶有BRAF V600突變的病人接受Zelboraf(vemurafenib)治療。(以下空白)",
    "醫器規格": "cobas&reg; 4800 BRAF V600 Mutation Test 24 Tests (P\/N:05985595190)",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "1903101100  台灣羅氏醫療診斷設備股份有限公司",
    "申請商地址": "台北市中山區民權東路3段2號10樓",
    "主製造廠": {
        "製造廠名稱": "MUS1033100  ROCHE MOLECULAR SYSTEMS, INC.",
        "製造廠廠址": "1080 US HIGHWAY 202 SOUTH BRANCHBURG, NJ-08876, USA",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060247210002___20130329.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024721&Seq=001&Type=9"
        },
        {
            "title": "060247210001___20130329.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024721&Seq=001&Type=8"
        }
    ]
}